$CHKP
CHECK POINT SOFTWARE TECHNOLOGIES LTD

2023 Q4 Form 20-F Financial Statement

#000117891324001196 Filed on April 02, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $663.5M $2.415B
YoY Change 3.92% 3.64%
Cost Of Revenue $81.50M $282.6M
YoY Change -2.74% -7.16%
Gross Profit $582.0M $2.132B
YoY Change 4.92% 5.26%
Gross Profit Margin 87.72% 88.3%
Selling, General & Admin $221.1M $850.4M
YoY Change 5.89% 8.04%
% of Gross Profit 37.99% 39.89%
Research & Development $98.00M $361.9M
YoY Change 8.89% 5.57%
% of Gross Profit 16.84% 16.97%
Depreciation & Amortization $19.20M $47.40M
YoY Change 102.11% 30.94%
% of Gross Profit 3.3% 2.22%
Operating Expenses $330.2M $1.233B
YoY Change 9.81% 8.04%
Operating Profit $251.8M $899.1M
YoY Change -0.87% 1.67%
Interest Expense $18.40M $76.50M
YoY Change 20.26% 73.86%
% of Operating Profit 7.31% 8.51%
Other Income/Expense, Net -$5.400M
YoY Change -73.4%
Pretax Income $270.2M $975.6M
YoY Change 0.33% 5.1%
Income Tax $21.00M $135.3M
% Of Pretax Income 7.77% 13.87%
Net Earnings $249.2M $840.3M
YoY Change -7.67% 5.45%
Net Earnings / Revenue 37.56% 34.8%
Basic Earnings Per Share $7.19
Diluted Earnings Per Share $2.15 $7.10
COMMON SHARES
Basic Shares Outstanding 112.9M 116.9M
Diluted Shares Outstanding 118.3M

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.530B $1.530B
YoY Change -6.57% -6.57%
Cash & Equivalents $537.7M $537.7M
Short-Term Investments $992.3M $992.3M
Other Short-Term Assets $70.00M $70.00M
YoY Change 40.0% 40.0%
Inventory
Prepaid Expenses
Receivables $657.7M $657.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.258B $2.258B
YoY Change -3.18% -3.18%
LONG-TERM ASSETS
Property, Plant & Equipment $80.40M $80.40M
YoY Change -2.9% -2.9%
Goodwill $1.554B
YoY Change 25.69%
Intangibles
YoY Change
Long-Term Investments $1.430B $1.430B
YoY Change -23.37% -23.37%
Other Assets $179.2M $179.2M
YoY Change 20.19% 20.19%
Total Long-Term Assets $3.438B $3.438B
YoY Change 1.32% 1.32%
TOTAL ASSETS
Total Short-Term Assets $2.258B $2.258B
Total Long-Term Assets $3.438B $3.438B
Total Assets $5.696B $5.696B
YoY Change -0.51% -0.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $502.3M $502.3M
YoY Change 5.57% 5.57%
Accrued Expenses $454.0M $449.3M
YoY Change 104.04% 2.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.916B $1.916B
YoY Change 4.18% 4.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $958.4M $958.4M
YoY Change 0.22% 0.22%
Total Long-Term Liabilities $958.4M $958.4M
YoY Change 0.22% 0.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.916B $1.916B
Total Long-Term Liabilities $958.4M $958.4M
Total Liabilities $2.875B $2.875B
YoY Change 2.83% 2.83%
SHAREHOLDERS EQUITY
Retained Earnings $13.17B
YoY Change 6.82%
Common Stock $2.733B
YoY Change 9.27%
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.04B
YoY Change 10.5%
Treasury Stock Shares
Shareholders Equity $2.821B $2.821B
YoY Change
Total Liabilities & Shareholders Equity $5.696B $5.696B
YoY Change -0.51% -0.51%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $249.2M $840.3M
YoY Change -7.67% 5.45%
Depreciation, Depletion And Amortization $19.20M $47.40M
YoY Change 102.11% 30.94%
Cash From Operating Activities $271.2M $1.099B
YoY Change 10.51% 14.67%
INVESTING ACTIVITIES
Capital Expenditures $4.700M $18.60M
YoY Change -27.69% -15.84%
Acquisitions $458.8M
YoY Change 849.9%
Other Investing Activities -$3.800M -$458.8M
YoY Change 849.9%
Cash From Investing Activities -$8.500M -$477.4M
YoY Change 30.77% 578.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$297.2M -$1.154B
YoY Change -2.3% -0.42%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -298.4M -1.165B
YoY Change -2.26% -0.27%
NET CHANGE
Cash From Operating Activities 271.2M 1.099B
Cash From Investing Activities -8.500M -477.4M
Cash From Financing Activities -298.4M -1.165B
Net Change In Cash -35.70M -543.5M
YoY Change -46.23% 93.97%
FREE CASH FLOW
Cash From Operating Activities $271.2M $1.099B
Capital Expenditures $4.700M $18.60M
Free Cash Flow $266.5M $1.080B
YoY Change 11.55% 15.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001015922
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L3
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-28584
CY2023 dei Entity Registrant Name
EntityRegistrantName
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
5 Shlomo Kaplan Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Tel Aviv
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
6789159
CY2023 dei Entity Address Country
EntityAddressCountry
IL
CY2023 dei Security12b Title
Security12bTitle
Ordinary shares
CY2023 dei Trading Symbol
TradingSymbol
CHKP
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
112906427
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
1281
CY2023 dei Auditor Name
AuditorName
Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global
CY2023 dei Auditor Location
AuditorLocation
Tel-Aviv, Israel
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
537700000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196000000
CY2023Q4 chkp Short Term Deposit
ShortTermDeposit
52500000
CY2022Q4 chkp Short Term Deposit
ShortTermDeposit
431100000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
939800000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1010500000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
657700000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
644200000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
70000000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50000000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2257700000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2331800000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1429700000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1865600000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80400000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82800000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
81800000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
77600000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
194100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58800000
CY2023Q4 us-gaap Goodwill
Goodwill
1554400000
CY2022Q4 us-gaap Goodwill
Goodwill
1236700000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
97400000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71500000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3437800000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3393000000
CY2023Q4 us-gaap Assets
Assets
5695500000
CY2022Q4 us-gaap Assets
Assets
5724800000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
48300000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
29600000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
241800000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
223700000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1413800000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1363400000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
212200000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
222500000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1916100000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1839200000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
493900000
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
514400000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
436100000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
419700000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28400000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22200000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
958400000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
956300000
CY2023Q4 us-gaap Liabilities
Liabilities
2874500000
CY2022Q4 us-gaap Liabilities
Liabilities
2795500000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
261223970
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
261223970
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112906427
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120761971
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
800000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
800000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2732500000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2500700000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
148317543
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
140461999
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
13041200000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
11802100000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39200000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-97900000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13168100000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12327800000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2821000000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2929300000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5695500000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5724800000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2414700000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2329900000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2166800000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
282600000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
304400000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
258100000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
368900000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
349900000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
292700000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
747100000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
675200000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
597800000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
117000000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
116100000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
110700000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
1515600000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
1445600000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
1259300000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
899100000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
884300000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
907500000
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
76500000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
44000000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
42100000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
975600000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
928300000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
949600000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
135300000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131400000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
134000000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
840300000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
796900000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
815600000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.19
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.37
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.13
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116913913
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125205504
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133121763
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.1
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.31
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.08
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118347749
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126338989
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134110048
CY2023 us-gaap Net Income Loss
NetIncomeLoss
840300000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
796900000
CY2022 us-gaap Profit Loss
ProfitLoss
796900000
CY2021 us-gaap Profit Loss
ProfitLoss
815600000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23100000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
815600000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
49100000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-93400000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-38500000
CY2023 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-5200000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1700000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
54300000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-93400000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-40200000
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-12000000
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-25400000
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-100000
CY2023 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
16400000
CY2022 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
21500000
CY2021 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-1000000
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4400000
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3900000
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1100000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
58700000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-97300000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-41300000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
899000000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
699600000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
774300000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3466200000
CY2021 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
2872272
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
194000000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
10900938
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1299500000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
120300000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-41300000
CY2021 chkp Adjustments To Additional Paid In Capital Fair Value Of Awards Attributable To Pre Acquisition Services
AdjustmentsToAdditionalPaidInCapitalFairValueOfAwardsAttributableToPreAcquisitionServices
1800000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
815600000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3257100000
CY2022 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
2094108
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
141100000
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
10324181
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1299900000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
131400000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-97300000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
796900000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2929300000
CY2023 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
2001548
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
133700000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9857092
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1287600000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
145300000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
58700000
CY2023 chkp Adjustments To Additional Paid In Capital Fair Value Of Awards Attributable To Pre Acquisition Services
AdjustmentsToAdditionalPaidInCapitalFairValueOfAwardsAttributableToPreAcquisitionServices
1300000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
840300000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2821000000
CY2023 us-gaap Profit Loss
ProfitLoss
840300000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22700000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20600000
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3100000
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18500000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
21000000
CY2023 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-6700000
CY2022 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0
CY2021 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1400000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24300000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13500000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10100000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
145300000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
131400000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
120300000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9500000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-500000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4000000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9900000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
46100000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51600000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
51100000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-100000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1200000
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
17900000
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
19800000
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-7700000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
26700000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
26300000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8900000
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-900000
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-54600000
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
66400000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
21800000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
170300000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
216800000
CY2023 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
100000
CY2022 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
200000
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
5500000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1037900000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1098500000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1203900000
CY2023 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
510600000
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
538400000
CY2021 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
214500000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1022900000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1056600000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1551700000
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
491900000
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
9100000
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
184100000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
947300000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1063100000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1297500000
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
132000000
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
477000000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
492500000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
458800000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15900000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
468700000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
48300000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
219700000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18600000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22100000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6400000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75300000
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
133700000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
141200000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
194000000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1287600000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1299900000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1299500000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9300000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6900000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1164900000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1168000000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1112400000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
341700000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-75900000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16200000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271900000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
255700000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
537700000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271900000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
118700000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
113500000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
101000000
CY2023 chkp Fair Value Of Awards Attributable To Pre Acquisition Services
FairValueOfAwardsAttributableToPreAcquisitionServices
1300000
CY2022 chkp Fair Value Of Awards Attributable To Pre Acquisition Services
FairValueOfAwardsAttributableToPreAcquisitionServices
0
CY2021 chkp Fair Value Of Awards Attributable To Pre Acquisition Services
FairValueOfAwardsAttributableToPreAcquisitionServices
1800000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2300000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8000000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1400000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 unit_segment
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 unit_segment
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
301200000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
301200000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:0pt;margin-bottom:0pt"> <div> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:73.4pt"> </td> <td style="width:24.5pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates:</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="vertical-align:top;font-family:Times New Roman, serif;width:97pt"> </td> <td style="vertical-align:top;text-align:justify;width:auto"> <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></span></div> </td> </tr> </table> </div> </div> </div> </div> </div>
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21500000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
26100000
CY2023 us-gaap Payments For Rent
PaymentsForRent
7700000
CY2022 us-gaap Payments For Rent
PaymentsForRent
6300000
CY2021 us-gaap Payments For Rent
PaymentsForRent
8100000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 unit_segment
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2249000000
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2146100000
CY2023 chkp Revenue Remaining Performance Obligation Next Twelve Months
RevenueRemainingPerformanceObligationNextTwelveMonths
1502700000
CY2023 chkp Provision For Estimated Sales Returns Rebates Stock Rotations And Other Customer Rights
ProvisionForEstimatedSalesReturnsRebatesStockRotationsAndOtherCustomerRights
10200000
CY2022 chkp Provision For Estimated Sales Returns Rebates Stock Rotations And Other Customer Rights
ProvisionForEstimatedSalesReturnsRebatesStockRotationsAndOtherCustomerRights
9500000
CY2023 chkp Percentage Of Employee Contributions Contributed By Employer Towards Employee Benefit Plan
PercentageOfEmployeeContributionsContributedByEmployerTowardsEmployeeBenefitPlan
0.50
CY2023 chkp Maximum Percentage Of Employees Eligible Compensation
MaximumPercentageOfEmployeesEligibleCompensation
0.06
CY2023 chkp Minimum Percentage Of Tax Benefit Realized Upon Settlement
MinimumPercentageOfTaxBenefitRealizedUponSettlement
0.50
CY2023 us-gaap Advertising Expense
AdvertisingExpense
7600000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
4600000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
4100000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:0pt;margin-bottom:0pt"> <div> <div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:73.4pt"> </td> <td style="width:24.5pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentrations of credit risk:</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:97.9pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments that could potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, short-term bank deposits, marketable securities, trade receivables and foreign currency derivative contracts.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:97.9pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The majority of the Company’s cash and cash equivalents and short-term bank deposits are deposited in major banks in the U.S., Israel and Europe. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Marketable securities are held mainly by Check Point Ltd., the Company’s Singaporean subsidiary, Canadian subsidiary and the U.S. subsidiary, and are invested in securities denominated in US dollar.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:97.9pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company’s marketable securities consist mainly of investments in government, corporate and government sponsored enterprises debentures. The Company’s investment policy, approved by the Board of Directors, limits the amount that the Company may invest in any one type of investment, or issuer, thereby reducing credit risk concentrations.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:97.9pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company’s trade receivables are geographically dispersed and the majority is derived from sales to channel partners mainly in the United States, Europe and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures.</span></span></div> </div> </div> </div>
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18600000
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
24400000
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1100000
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1309068000000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1730104000000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4891452000000
CY2023Q4 us-gaap Cash
Cash
79800000
CY2022Q4 us-gaap Cash
Cash
65800000
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
175400000
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
95500000
CY2023Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
282500000
CY2022Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
34700000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
537700000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196000000
CY2023Q4 us-gaap Due From Banks
DueFromBanks
52500000
CY2022Q4 us-gaap Due From Banks
DueFromBanks
431100000
CY2023Q4 chkp Fair Value Of Marketable Securities By Contractual Maturities
FairValueOfMarketableSecuritiesByContractualMaturities
2369500000
CY2022Q4 chkp Fair Value Of Marketable Securities By Contractual Maturities
FairValueOfMarketableSecuritiesByContractualMaturities
2876100000
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
2959700000
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
3503200000
CY2023Q4 chkp Amortized Cost Of Marketable Securities By Contractual Maturities
AmortizedCostOfMarketableSecuritiesByContractualMaturities
-2422000000
CY2023Q4 chkp Gross Unrealized Gain Of Marketable Securities By Contractual Maturity
GrossUnrealizedGainOfMarketableSecuritiesByContractualMaturity
-3000000
CY2023Q4 chkp Gross Unrealized Loss Of Marketable Securities By Contractual Maturity
GrossUnrealizedLossOfMarketableSecuritiesByContractualMaturity
-55500000
CY2023Q4 chkp Fair Value Of Marketable Securities By Contractual Maturities
FairValueOfMarketableSecuritiesByContractualMaturities
2369500000
CY2022Q4 chkp Amortized Cost Of Marketable Securities By Contractual Maturities
AmortizedCostOfMarketableSecuritiesByContractualMaturities
-2999400000
CY2022Q4 chkp Gross Unrealized Gain Of Marketable Securities By Contractual Maturity
GrossUnrealizedGainOfMarketableSecuritiesByContractualMaturity
-100000
CY2022Q4 chkp Gross Unrealized Loss Of Marketable Securities By Contractual Maturity
GrossUnrealizedLossOfMarketableSecuritiesByContractualMaturity
-123400000
CY2022Q4 chkp Fair Value Of Marketable Securities By Contractual Maturities
FairValueOfMarketableSecuritiesByContractualMaturities
2876100000
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
55500000
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
123400000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
41900000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
87300000
CY2023Q4 chkp Short Term Bank Deposits Fair Value Disclosure
ShortTermBankDepositsFairValueDisclosure
52500000
CY2022Q4 chkp Short Term Bank Deposits Fair Value Disclosure
ShortTermBankDepositsFairValueDisclosure
431100000
CY2023Q4 chkp Foreign Currency Derivative Contract Asset Fair Value Disclosure
ForeignCurrencyDerivativeContractAssetFairValueDisclosure
1300000
CY2022Q4 chkp Foreign Currency Derivative Contract Asset Fair Value Disclosure
ForeignCurrencyDerivativeContractAssetFairValueDisclosure
-3600000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2961000000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
3499600000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
214000000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
195500000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
133600000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
112700000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80400000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82800000
CY2022Q4 us-gaap Goodwill
Goodwill
1236700000
CY2021Q4 us-gaap Goodwill
Goodwill
1196200000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
317700000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
40500000
CY2023Q4 us-gaap Goodwill
Goodwill
1554400000
CY2022Q4 us-gaap Goodwill
Goodwill
1236700000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
124800000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
72300000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
66000000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
194100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58800000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
53900000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
44800000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
21800000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
18700000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
17500000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
37400000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
194100000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
928300000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
949600000
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
1907700000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1877800000
CY2023Q4 chkp Accrued Products And Licenses Costs
AccruedProductsAndLicensesCosts
73900000
CY2022Q4 chkp Accrued Products And Licenses Costs
AccruedProductsAndLicensesCosts
84400000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4700000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
8700000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
40700000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
34300000
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
27800000
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
32000000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
65100000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63100000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
212200000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
222500000
CY2023 chkp Corporate Income Tax Rate
CorporateIncomeTaxRate
0.23
CY2023Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
546900000
CY2023Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
89600000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36200000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38700000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
30300000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
34900000
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3000000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3500000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
32500000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
29800000
CY2023Q4 chkp Deferred Tax Assets Unrealized Gains On Marketable Securities Net
DeferredTaxAssetsUnrealizedGainsOnMarketableSecuritiesNet
11800000
CY2022Q4 chkp Deferred Tax Assets Unrealized Gains On Marketable Securities Net
DeferredTaxAssetsUnrealizedGainsOnMarketableSecuritiesNet
29600000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
13200000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
11300000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
17300000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
16300000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
144300000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
164100000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16700000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17500000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
127600000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
146600000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
13400000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
32800000
CY2023Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
9300000
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
3800000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
6100000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
15800000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
28800000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
52400000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
98800000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
94200000
CY2023Q4 chkp Unrecognized Tax Benefit Presented Net From Deferred Tax Asset
UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset
17000000
CY2022Q4 chkp Unrecognized Tax Benefit Presented Net From Deferred Tax Asset
UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset
16600000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
901600000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
897400000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
917900000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
74000000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
30900000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
31700000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
975600000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
135300000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131400000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
134000000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436300000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
469500000
CY2023 chkp Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
-35200000
CY2022 chkp Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
-85400000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
51900000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
52200000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
453000000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436300000
CY2023Q4 chkp Unrecognized Tax Benefit Presented Net From Deferred Tax Asset
UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset
17000000
CY2022Q4 chkp Unrecognized Tax Benefit Presented Net From Deferred Tax Asset
UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset
16600000
CY2023 chkp Interest Expense Uncertain Tax Positions
InterestExpenseUncertainTaxPositions
12600000
CY2022 chkp Interest Expense Uncertain Tax Positions
InterestExpenseUncertainTaxPositions
15900000
CY2021 chkp Interest Expense Uncertain Tax Positions
InterestExpenseUncertainTaxPositions
9700000
CY2023Q4 chkp Accrued Interest On Uncertain Tax Positions
AccruedInterestOnUncertainTaxPositions
72600000
CY2022Q4 chkp Accrued Interest On Uncertain Tax Positions
AccruedInterestOnUncertainTaxPositions
60000000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
975600000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
928300000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
949600000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.08
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.13
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.11
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.01
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.04
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.02
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.14
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.14
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.14
CY2023 chkp Basic Earnings Per Shares Amount Resulting From Issuance Of Status
BasicEarningsPerSharesAmountResultingFromIssuanceOfStatus
0.66
CY2022 chkp Basic Earnings Per Shares Amount Resulting From Issuance Of Status
BasicEarningsPerSharesAmountResultingFromIssuanceOfStatus
0.95
CY2021 chkp Basic Earnings Per Shares Amount Resulting From Issuance Of Status
BasicEarningsPerSharesAmountResultingFromIssuanceOfStatus
0.8
CY2023 chkp Diluted Earnings Per Shares Amount Resulting From Issuance Of Status
DilutedEarningsPerSharesAmountResultingFromIssuanceOfStatus
0.65
CY2022 chkp Diluted Earnings Per Shares Amount Resulting From Issuance Of Status
DilutedEarningsPerSharesAmountResultingFromIssuanceOfStatus
0.94
CY2021 chkp Diluted Earnings Per Shares Amount Resulting From Issuance Of Status
DilutedEarningsPerSharesAmountResultingFromIssuanceOfStatus
0.8
CY2023Q4 chkp Stock Repurchase Program Cumulative Shares Repurchased Value
StockRepurchaseProgramCumulativeSharesRepurchasedValue
14372700000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9857092
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
10324181
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
10900938
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1287600000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1299900000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1299500000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7233044
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2289731
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
12290744
CY2023Q4 chkp Share Based Compensation Aggregate Amount Including Options And Units Aggregate Share Outstanding
ShareBasedCompensationAggregateAmountIncludingOptionsAndUnitsAggregateShareOutstanding
122907440
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7778108
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
115.05
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
82500000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
585000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
131.9
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
920253
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
110.12
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
209811
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
127.22
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7233044
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
117.5
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
255300000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5902708
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
115.74
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
218700000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
43
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.6
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.9
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20000000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
32900000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
65100000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2408346
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1410675
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
763148
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
287904
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2767969
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
96100000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
89400000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
66800000
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
311700000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
145300000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
131400000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
120300000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
840300000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
796900000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
815600000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116913913
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125205504
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133121763
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1433836
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1133485
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
988285
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118347749
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126338989
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134110048
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.19
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.37
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.13
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.1
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.31
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.08
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-97900000
CY2023 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
37100000
CY2023 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
21600000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
58700000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39200000
CY2023 us-gaap Revenues
Revenues
2414700000
CY2022 us-gaap Revenues
Revenues
2329900000
CY2021 us-gaap Revenues
Revenues
2166800000
CY2023Q4 chkp Property Plant And Equipment Net And Right Of Use Assets
PropertyPlantAndEquipmentNetAndRightOfUseAssets
101900000
CY2022Q4 chkp Property Plant And Equipment Net And Right Of Use Assets
PropertyPlantAndEquipmentNetAndRightOfUseAssets
103500000
CY2023 chkp Number Of Product Lines
NumberOfProductLines
3 unit_product
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2414700000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2329900000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2166800000
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
76500000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
44000000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
42100000

Files In Submission

Name View Source Status
0001178913-24-001196-index-headers.html Edgar Link pending
0001178913-24-001196-index.html Edgar Link pending
0001178913-24-001196.txt Edgar Link pending
0001178913-24-001196-xbrl.zip Edgar Link pending
chkp-20231231.xsd Edgar Link pending
chkp_img01.jpg Edgar Link pending
chkp_img02.jpg Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_12-2.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
exhibit_13-2.htm Edgar Link pending
exhibit_15.htm Edgar Link pending
exhibit_2-1.htm Edgar Link pending
exhibit_4-2.htm Edgar Link pending
exhibit_4-3.htm Edgar Link pending
exhibit_4-9.htm Edgar Link pending
exhibit_97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
chkp-20231231_cal.xml Edgar Link unprocessable
chkp-20231231_def.xml Edgar Link unprocessable
chkp-20231231_pre.xml Edgar Link unprocessable
chkp-20231231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk2431186.htm Edgar Link pending
zk2431186_htm.xml Edgar Link completed